Codexis, Inc. (CDXS) Appoints David O'Toole as Chief Financial Officer
9/4/2012 10:31:58 AM
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals, today announced the appointment of David O’Toole as Senior Vice President and Chief Financial Officer, effective September 4, 2012. David O’Toole served most recently as Vice President and Chief Financial Officer at Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer and analytical testing services of clinical trial specimens for the pharmaceutical industry. In this role, David managed the finance and accounting department and was responsible for investor relations and information technologies. During David’s time at Response Genetics, he implemented policies and procedures across all company functions that resulted in significant cost savings and operational efficiencies for the business. David also successfully completed a number of equity financings.
comments powered by